Yoda Pharmaceuticals Inc. (TPEX:7829)

Market Cap	4.61B
Revenue (ttm)	n/a
Net Income (ttm)	-315.73M
Shares Out	79.39M
EPS (ttm)	-4.35
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	178,720
Average Volume	100,784
Open	57.70
Previous Close	58.20
Day's Range	57.20 - 58.50
52-Week Range	32.65 - 77.60
Beta	n/a
RSI	44.88
Earnings Date	Apr 29, 2026

About Yoda Pharmaceuticals

Yoda Pharmaceuticals Inc., an AI-driven company, focuses on development of drugs targeting central nervous system disorders. The company’s flagship drug, YA-101 is in Phase 2 clinical trial for the treatment of multiple system atrophy. It is also involved in the development pipeline includes drugs in the field of neurological and psychiatric disorders and cerebrovascular diseases, targeting conditions, such as schizophrenia, Alzheimer's disease, Parkinson‘s disease, Autism, ischemic stroke, and traumatic brain injury. Yoda Pharmaceuticals Inc. ...

• Industry: Pharmaceutical Preparations
• Founded: 2019
• Country: Cayman Islands
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7829